EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieDelphi-StudieOpen Access · CC BY-NC-ND 4.0

Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus

Faming Zhang iD, Michael A Kamm iD, Xia Wu, Dina Kao, Thomas J Borody, Lea Ann Chen iD, Xingxiang He, Monika Fischer, Sunny H Wong iD, Siew C Ng iD, Bota Cui iD, Francis K-L Chan und 11 weitere

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.16947 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Faming Zhang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, C…. Hauptthemen laut MEDLINE: Delphi Technique, Dysbiosis, Practice Guidelines as Topic, Checklist. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Natural Science Fundation of China, Ministry of Science and Technology of China, National Key Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microbiotherapy has opened new avenues for managing dysbiosis‐related diseases. However, many studies did not cover all the necessary reporting items for microbiotherapy making the interpretation of results, safety assessment, technology extension, and even the transparency of legitimacy difficult. This project consisted of 2 phases. First, we proposed an initial preferred reporting items for microbiotherapy (PRIM) checklist and applied it to oncology studies from 2011 to 2023 according to Meta‐Analyses guideline. Only 39.3% ( n = 64) of these studies ( n = 163) met all PRIM checklist items. The culture‐based microbiotherapy (CMT) studies had higher score than non‐culture‐based (NMT) ones ( p = 0.018). In the second phase, the expert panel consisting of 22 specialists from eight countries across Asia, Australia, Europe, and North America refined and finalized the PRIM guidelines (named as PRIM 2024) through Delphi consensus. The PRIM 2024 guidelines conclude 10 statements and 18 points on diagnosis, delivery route, source, classification, preparation, dosage, state, concomitant treatment, efficacy, and safety. The panel defined less than 80% of all PRIM points (14 points) as low‐quality reports. These guidelines are recommended for reporting on microbiotherapy in clinical studies and reports on compassionate use, including but not limited to fecal microbiota transplantation, phage therapy, probiotics, and synbiotics. These consistent and transparent reporting items can help researchers and practitioners better evaluate, compare, implement research findings in microbiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Delphi TechniqueDysbiosisPractice Guidelines as TopicChecklistHumansConsensusFecal Microbiota TransplantationInternationality

Stichwörter der Autor:innen

microbiomemicrobiota transplantationphagesprobioticsspores

Autor:innen und Institutionen

  • Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  • Center for Digestive Diseases, Sydney, New South Wales, Australia.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers, New Brunswick, USA.
  • Department of Gastroenterology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

ORCID-Profile: Faming Zhang, Michael A Kamm, Lea Ann Chen, Sunny H Wong, Siew C Ng, Bota Cui, Jingnan Li, Muhan Lv

Förderung

  • NIDDK NIH HHS
  • National Natural Science Fundation of China
  • Ministry of Science and Technology of China, National Key Program
  • Nanjing Medical University Fan Daiming Research Funds for Holistic Integrative Medicine

Zitieren

APA

Zhang, F., Kamm, M. A., Wu, X., Kao, D., Borody, T. J., Chen, L. A., He, X., Fischer, M., Wong, S. H., Ng, S. C., Cui, B., Chan, F. K., Nie, Y., Sood, A., Li, J., Sun, Y., Dai, I., Chen, Q., Lv, M., …, & Kelly, C. R. (2025). Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16947

Vancouver

Zhang F, Kamm MA, Wu X, Kao D, Borody TJ, Chen LA, et al. Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16947

BibTeX
@article{Zhang2025,
  author = {Zhang, Faming and Kamm, Michael A and Wu, Xia and Kao, Dina and Borody, Thomas J and Chen, Lea Ann and He, Xingxiang and Fischer, Monika and Wong, Sunny H and Ng, Siew C and Cui, Bota and Chan, Francis K-L and Nie, Yongzhan and Sood, Ajit and Li, Jingnan and Sun, Yang and Dai, Ishikawa and Chen, Qiyi and Lv, Muhan and Zhang, Zulun and Ianiro, Gianluca and Yang, Yunsheng and Kelly, Colleen R},
  title = {Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.16947}
}
Kostenlos starten →